Health

Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration

TOKYO and NANJING, China, Dec. 18, 2020 /PRNewswire/ -- Teijin Pharma Limited  ("Teijin Pharma"), the core company of the Teijin Group 's healthcare business headquartered in Tokyo, Japan, and TransThera Biosciences Co. Ltd. ("TransThera"),...

2020-12-18 23:30 3861

Medtecs Chosen as Asian Development Bank's Partner to Supply Vital PPE to Asian Developing Countries Amidst COVID-19 Pandemic

TAIPEI, Dec. 18, 2020 /PRNewswire/ -- Medtecs Group, a leading personal protective equipment (PPE) supplier based inTaiwan, had passed the rigorous procurement process of the Asian Development Bank (ADB) inJune 2020 to become the ADB's supplier of critical protective gear for frontline health wor...

2020-12-18 18:22 2553

Amidst COVID-19 Pandemic, Medtecs Group Transforms Itself into the World's Biggest Stockpiling Solutions Provider

TAIPEI, Dec. 18, 2020 /PRNewswire/ -- Taiwan has been lauded by international communities for its standout performance in containing the outbreak of the coronavirus (COVID-19). In the meantime, Medtecs Group, a company headquartered inTaipei, Taiwan has taken off to become the world's leading sup...

2020-12-18 15:27 1876

Beijing steps up efforts of further opening up

BEIJING, Dec. 17, 2020 /PRNewswire/ -- This is a report from China.org.cn: Beijing received approval from the State Council in September to build a comprehensive demonstration zone for further opening up the service sector and a pilot free trade zone. Since then, it has completed 57 out of its pl...

2020-12-18 12:33 2048

I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic

I Peace's GMP-grade iPSCs are key to manufacture Avery Therapeutics' MyCardia™, a proprietary tissue-engineered heart graft developed to treat heart failure TUCSON, Ariz. and PALO ALTO, Calif., Dec. 16, 2020 /PRNewswire/ -- Avery Therapeutics, aTucson-based company dedicated to advancing tissue-e...

2020-12-17 08:41 2092

[Ending poverty in China: Data speak] How to solve the problem of poverty caused by ill-health

BEIJING, Dec. 16, 2020 /PRNewswire/ -- A video by China.org.cn: China's poverty reduction work about health care. How didChina solve the problem of poverty caused by ill-health.   In the past 70 years, life expectancy in China has improved from 35 to 77.3 years, higher than glo...

2020-12-16 22:00 1945

SOS Ltd. Announces Strategic Cooperation Agreement with Qingdao West Coast Healthcare Development Group

QINGDAO, China, Dec. 16, 2020 /PRNewswire/ -- SOS Limited (NYSE: SOS) (the "Company" or "SOS") announced today that it entered into a strategic cooperation agreement withQingdao West Coast Healthcare Development Group Co., Ltd  ("Qingdao Healthcare") to cooperate in the area of health management,...

2020-12-16 21:15 5911

New data confirms Smith+Nephew technology as the best performing cementless construct for Total Hip Arthroplasty¹

Components of the POLAR3™ Total Hip Solution excel at ten and fifteen year benchmarks in global registries LONDON, Dec. 16, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced outstanding clinical results for its total hip arthroplasty (T...

2020-12-16 21:00 6873

Happy Buy Receives Policy Granting 80% Tax Rebates From Local Government

NANPING, China, Dec. 16, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that Happy Buy, the Company's wholly-owned subsidiary focusing on e-commerce business, received p...

2020-12-16 21:00 9442

Samsung Biologics Names John Rim as President and CEO

INCHEON, South Korea, Dec. 16, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announcedJohn Rim as its President and CEO. The appointment was made effective immediately and formalized via the company's board of directors meeting today.

2020-12-16 20:00 1971

Chargebee and Eagle Eye partner to offer subscription services to help retail and hospitality companies drive recurring revenue

SAN FRANCISCO, Dec. 15, 2020 /PRNewswire/ -- Chargebee, the leading subscription billing and revenue management platform, today announced its partnership withEagle Eye Solutions (Eagle Eye), a SaaS-based provider enabling one-to-one performance marketing, to help retai...

2020-12-15 22:29 1707

Clarity Pharmaceuticals closes $25m capital raising

SYDNEY, Dec. 15, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has completed a capital raising of$25,000,410. Dr Alan Taylor, Executive Chairman of Clarity Pharmaceuticals, co...

2020-12-15 22:12 2462

Appian Selected by Accenture as a Core Partner in the INTIENT Network for Life Sciences

Appian brings low-code speed and automation power to help drive innovation in drug discovery and scientific research MCLEAN, Va., Dec. 15, 2020 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced that it has joined Accenture's INTIENT partner ecosystem as a core partner. The ecosystem is desig...

2020-12-15 22:00 4273

Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products

SAN DIEGO and SHANGHAI, Dec. 15, 2020 /PRNewswire/ -- Singlera Genomics Inc. today announced that it raised$150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Capital and Furong Investment. The new group of inve...

2020-12-15 22:00 1767

GMAX Zhengzhou Manufacturing Site Breaks Ground

HANGZHOU, China, Dec. 15, 2020 /PRNewswire/ -- Gmax Biopharm today holds ground-breaking ceremony for itsZhengzhou, China manufacturing site which is the production base for its GMA102 (T2D), GMA105 (obesity), and GMA301A/B (PAH for adult and children) drugs to be launched between 2023-2025, upon...

2020-12-15 18:00 1499

Ruben S. Martin III Elected Chairman Of Mercy Ships International's Board Of Directors

Highly Accomplished Business Leader and Philanthropist has been a Long-Time Board Member and Supporter of Mercy Ships and its Work to Bring Hope and Healing to the World's Most Disadvantaged Peoples GARDEN VALLEY, Texas, Dec. 14, 2020 /PRNewswire/ -- Mercy Ships, the global healthcare charity th...

2020-12-14 23:00 3744

Mercy Ships Announces Retirement Of Board Chairman Myron Ullman, Who Has Been Instrumental In Achieving Its Mission Of Bringing Hope And Healing To The World's Most Disadvantaged Peoples

Since he became Chairman in 2001, Mercy Ships has seen exceptional growth including reaching the milestone of performing more than 100,000 surgical procedures on board its charity hospital ships, attracting 20,000 volunteers from 60 nations, and providing healthcare services and materials worth m...

2020-12-14 23:00 1628

Sunshine Guojian Selects Verseau's VSIG4-targeted Antibody as the Second Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- 3SBio Inc. ("3SBio")'s subsidiary, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. ("Sunshine Guojian") and Verseau Therapeutics, Inc.  ("Verseau") today announced the selection of a monoclonal antibody targeting VSIG4, as a ...

2020-12-14 22:28 2262

I-Mab Added to Nasdaq Biotechnology Index

SHANGHAI and GAITHERSBURG, Md., Dec. 14, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab's American Depositary Shares (ADS) have been ...

2020-12-14 21:00 9232

TCEB Leveraging MICE Personnel to Support Government's Special Arrangement for the Entry of Overseas Investors

BANGKOK, Dec. 14, 2020 /PRNewswire/ -- Thailand Convention and Exhibition Bureau (TCEB), in collaboration with Department of Disease Control, has launched the specialised training for Destination Management Company (DMC) to design health-compliant itineraries as part of a government's special ar...

2020-12-14 14:29 2311